nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium lauryl sulfate—ALB—Vandetanib—thyroid cancer	0.632	1	CbGbCtD
Sodium lauryl sulfate—Intestinal perforation—Vandetanib—thyroid cancer	0.0176	0.0478	CcSEcCtD
Sodium lauryl sulfate—Cellulitis—Vandetanib—thyroid cancer	0.00766	0.0208	CcSEcCtD
Sodium lauryl sulfate—Hypocalcaemia—Vandetanib—thyroid cancer	0.00761	0.0207	CcSEcCtD
Sodium lauryl sulfate—Creatinine increased—Vandetanib—thyroid cancer	0.00732	0.0199	CcSEcCtD
Sodium lauryl sulfate—Faecalith—Epirubicin—thyroid cancer	0.00608	0.0165	CcSEcCtD
Sodium lauryl sulfate—Faecaloma—Epirubicin—thyroid cancer	0.00608	0.0165	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Vandetanib—thyroid cancer	0.00604	0.0164	CcSEcCtD
Sodium lauryl sulfate—Faecaloma—Doxorubicin—thyroid cancer	0.00562	0.0153	CcSEcCtD
Sodium lauryl sulfate—Faecalith—Doxorubicin—thyroid cancer	0.00562	0.0153	CcSEcCtD
Sodium lauryl sulfate—Warmth—Epirubicin—thyroid cancer	0.00546	0.0148	CcSEcCtD
Sodium lauryl sulfate—Hypocalcaemia—Sorafenib—thyroid cancer	0.00513	0.0139	CcSEcCtD
Sodium lauryl sulfate—Hyperphosphataemia—Epirubicin—thyroid cancer	0.00508	0.0138	CcSEcCtD
Sodium lauryl sulfate—Warmth—Doxorubicin—thyroid cancer	0.00505	0.0137	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Vandetanib—thyroid cancer	0.00474	0.0129	CcSEcCtD
Sodium lauryl sulfate—Hyperphosphataemia—Doxorubicin—thyroid cancer	0.0047	0.0128	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Vandetanib—thyroid cancer	0.0047	0.0128	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Vandetanib—thyroid cancer	0.0046	0.0125	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Vandetanib—thyroid cancer	0.00437	0.0119	CcSEcCtD
Sodium lauryl sulfate—Bronchospasm—Vandetanib—thyroid cancer	0.0043	0.0117	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Vandetanib—thyroid cancer	0.0042	0.0114	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Vandetanib—thyroid cancer	0.00383	0.0104	CcSEcCtD
Sodium lauryl sulfate—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00376	0.0102	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Sorafenib—thyroid cancer	0.00369	0.01	CcSEcCtD
Sodium lauryl sulfate—Hypernatraemia—Epirubicin—thyroid cancer	0.0033	0.00896	CcSEcCtD
Sodium lauryl sulfate—Venous thrombosis—Epirubicin—thyroid cancer	0.00322	0.00873	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Sorafenib—thyroid cancer	0.00317	0.00861	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Vandetanib—thyroid cancer	0.00312	0.00848	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Sorafenib—thyroid cancer	0.0031	0.00842	CcSEcCtD
Sodium lauryl sulfate—Hypernatraemia—Doxorubicin—thyroid cancer	0.00306	0.00829	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Vandetanib—thyroid cancer	0.00298	0.00809	CcSEcCtD
Sodium lauryl sulfate—Venous thrombosis—Doxorubicin—thyroid cancer	0.00298	0.00808	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Sorafenib—thyroid cancer	0.00295	0.008	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Vandetanib—thyroid cancer	0.00287	0.00779	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Vandetanib—thyroid cancer	0.00268	0.00726	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Vandetanib—thyroid cancer	0.00264	0.00716	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Vandetanib—thyroid cancer	0.00259	0.00704	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00259	0.00703	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Sorafenib—thyroid cancer	0.00258	0.00701	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Vandetanib—thyroid cancer	0.00258	0.00701	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Sorafenib—thyroid cancer	0.00258	0.00699	CcSEcCtD
Sodium lauryl sulfate—Oedema—Vandetanib—thyroid cancer	0.00249	0.00674	CcSEcCtD
Sodium lauryl sulfate—Infection—Vandetanib—thyroid cancer	0.00247	0.0067	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Vandetanib—thyroid cancer	0.00223	0.00606	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Vandetanib—thyroid cancer	0.00222	0.00601	CcSEcCtD
Sodium lauryl sulfate—Feeling hot—Epirubicin—thyroid cancer	0.00221	0.006	CcSEcCtD
Sodium lauryl sulfate—Necrosis—Epirubicin—thyroid cancer	0.00221	0.006	CcSEcCtD
Sodium lauryl sulfate—Abscess—Epirubicin—thyroid cancer	0.00219	0.00596	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Vandetanib—thyroid cancer	0.00216	0.00586	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Vandetanib—thyroid cancer	0.00214	0.00582	CcSEcCtD
Sodium lauryl sulfate—Constipation—Vandetanib—thyroid cancer	0.00213	0.00577	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Sorafenib—thyroid cancer	0.00211	0.00572	CcSEcCtD
Sodium lauryl sulfate—Feeling hot—Doxorubicin—thyroid cancer	0.00205	0.00556	CcSEcCtD
Sodium lauryl sulfate—Necrosis—Doxorubicin—thyroid cancer	0.00205	0.00556	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00203	0.00552	CcSEcCtD
Sodium lauryl sulfate—Abscess—Doxorubicin—thyroid cancer	0.00203	0.00551	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Sorafenib—thyroid cancer	0.00201	0.00546	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Epirubicin—thyroid cancer	0.00199	0.0054	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Vandetanib—thyroid cancer	0.00196	0.00533	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Vandetanib—thyroid cancer	0.00196	0.00533	CcSEcCtD
Sodium lauryl sulfate—Cellulitis—Epirubicin—thyroid cancer	0.00191	0.00518	CcSEcCtD
Sodium lauryl sulfate—Hypocalcaemia—Epirubicin—thyroid cancer	0.0019	0.00515	CcSEcCtD
Sodium lauryl sulfate—Oliguria—Epirubicin—thyroid cancer	0.00188	0.00511	CcSEcCtD
Sodium lauryl sulfate—Syncope—Sorafenib—thyroid cancer	0.00184	0.005	CcSEcCtD
Sodium lauryl sulfate—Extravasation—Doxorubicin—thyroid cancer	0.00184	0.005	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Epirubicin—thyroid cancer	0.00184	0.00498	CcSEcCtD
Sodium lauryl sulfate—Creatinine increased—Epirubicin—thyroid cancer	0.00182	0.00495	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Sorafenib—thyroid cancer	0.00181	0.0049	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Vandetanib—thyroid cancer	0.00178	0.00484	CcSEcCtD
Sodium lauryl sulfate—Cellulitis—Doxorubicin—thyroid cancer	0.00177	0.0048	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Vandetanib—thyroid cancer	0.00176	0.00477	CcSEcCtD
Sodium lauryl sulfate—Hypocalcaemia—Doxorubicin—thyroid cancer	0.00176	0.00476	CcSEcCtD
Sodium lauryl sulfate—Oliguria—Doxorubicin—thyroid cancer	0.00174	0.00473	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Vandetanib—thyroid cancer	0.0017	0.00461	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Doxorubicin—thyroid cancer	0.0017	0.00461	CcSEcCtD
Sodium lauryl sulfate—Creatinine increased—Doxorubicin—thyroid cancer	0.00169	0.00458	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Sorafenib—thyroid cancer	0.00168	0.00455	CcSEcCtD
Sodium lauryl sulfate—Infection—Sorafenib—thyroid cancer	0.00167	0.00452	CcSEcCtD
Sodium lauryl sulfate—Shock—Sorafenib—thyroid cancer	0.00165	0.00448	CcSEcCtD
Sodium lauryl sulfate—Fluid retention—Epirubicin—thyroid cancer	0.00165	0.00447	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Vandetanib—thyroid cancer	0.00164	0.00446	CcSEcCtD
Sodium lauryl sulfate—Blood urea increased—Epirubicin—thyroid cancer	0.00164	0.00445	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Sorafenib—thyroid cancer	0.0016	0.00434	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Vandetanib—thyroid cancer	0.00158	0.00429	CcSEcCtD
Sodium lauryl sulfate—Rash—Vandetanib—thyroid cancer	0.00157	0.00425	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Vandetanib—thyroid cancer	0.00157	0.00425	CcSEcCtD
Sodium lauryl sulfate—Headache—Vandetanib—thyroid cancer	0.00156	0.00423	CcSEcCtD
Sodium lauryl sulfate—Fluid retention—Doxorubicin—thyroid cancer	0.00153	0.00414	CcSEcCtD
Sodium lauryl sulfate—Blood urea increased—Doxorubicin—thyroid cancer	0.00152	0.00412	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Epirubicin—thyroid cancer	0.00151	0.00409	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Sorafenib—thyroid cancer	0.00149	0.00406	CcSEcCtD
Sodium lauryl sulfate—Nausea—Vandetanib—thyroid cancer	0.00148	0.00401	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Epirubicin—thyroid cancer	0.00146	0.00397	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Sorafenib—thyroid cancer	0.00146	0.00396	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Sorafenib—thyroid cancer	0.00145	0.00392	CcSEcCtD
Sodium lauryl sulfate—Constipation—Sorafenib—thyroid cancer	0.00143	0.00389	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Doxorubicin—thyroid cancer	0.00139	0.00378	CcSEcCtD
Sodium lauryl sulfate—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00139	0.00377	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00137	0.00372	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Epirubicin—thyroid cancer	0.00137	0.00371	CcSEcCtD
Sodium lauryl sulfate—Phlebitis—Doxorubicin—thyroid cancer	0.00135	0.00367	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Sorafenib—thyroid cancer	0.00133	0.00361	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Sorafenib—thyroid cancer	0.00133	0.0036	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Sorafenib—thyroid cancer	0.00133	0.0036	CcSEcCtD
Sodium lauryl sulfate—Renal impairment—Epirubicin—thyroid cancer	0.00132	0.00359	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00129	0.00349	CcSEcCtD
Sodium lauryl sulfate—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00129	0.00349	CcSEcCtD
Sodium lauryl sulfate—Renal failure acute—Doxorubicin—thyroid cancer	0.00126	0.00343	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Sorafenib—thyroid cancer	0.00124	0.00335	CcSEcCtD
Sodium lauryl sulfate—Renal impairment—Doxorubicin—thyroid cancer	0.00123	0.00333	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Sorafenib—thyroid cancer	0.0012	0.00326	CcSEcCtD
Sodium lauryl sulfate—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00119	0.00323	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Sorafenib—thyroid cancer	0.00119	0.00322	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Epirubicin—thyroid cancer	0.00118	0.00321	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Epirubicin—thyroid cancer	0.00117	0.00318	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Epirubicin—thyroid cancer	0.00115	0.00311	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Sorafenib—thyroid cancer	0.00115	0.00311	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Sorafenib—thyroid cancer	0.00111	0.00301	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Epirubicin—thyroid cancer	0.0011	0.00298	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00109	0.00297	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Epirubicin—thyroid cancer	0.00109	0.00296	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Doxorubicin—thyroid cancer	0.00108	0.00294	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Sorafenib—thyroid cancer	0.00107	0.00289	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Doxorubicin—thyroid cancer	0.00106	0.00288	CcSEcCtD
Sodium lauryl sulfate—Rash—Sorafenib—thyroid cancer	0.00106	0.00287	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Sorafenib—thyroid cancer	0.00106	0.00287	CcSEcCtD
Sodium lauryl sulfate—Headache—Sorafenib—thyroid cancer	0.00105	0.00285	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Epirubicin—thyroid cancer	0.00105	0.00284	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Doxorubicin—thyroid cancer	0.00101	0.00275	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Doxorubicin—thyroid cancer	0.00101	0.00274	CcSEcCtD
Sodium lauryl sulfate—Nausea—Sorafenib—thyroid cancer	0.000996	0.0027	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Doxorubicin—thyroid cancer	0.000969	0.00263	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Epirubicin—thyroid cancer	0.000955	0.00259	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Doxorubicin—thyroid cancer	0.000884	0.0024	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Epirubicin—thyroid cancer	0.000868	0.00235	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000803	0.00218	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Epirubicin—thyroid cancer	0.000779	0.00211	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Epirubicin—thyroid cancer	0.000748	0.00203	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Epirubicin—thyroid cancer	0.000743	0.00202	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Doxorubicin—thyroid cancer	0.000721	0.00196	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Epirubicin—thyroid cancer	0.000715	0.00194	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Doxorubicin—thyroid cancer	0.000692	0.00188	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Doxorubicin—thyroid cancer	0.000688	0.00187	CcSEcCtD
Sodium lauryl sulfate—Syncope—Epirubicin—thyroid cancer	0.000681	0.00185	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Epirubicin—thyroid cancer	0.000671	0.00182	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Epirubicin—thyroid cancer	0.000667	0.00181	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Doxorubicin—thyroid cancer	0.000662	0.0018	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Epirubicin—thyroid cancer	0.000658	0.00179	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Epirubicin—thyroid cancer	0.000646	0.00175	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Epirubicin—thyroid cancer	0.000644	0.00175	CcSEcCtD
Sodium lauryl sulfate—Syncope—Doxorubicin—thyroid cancer	0.00063	0.00171	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Doxorubicin—thyroid cancer	0.000621	0.00168	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Epirubicin—thyroid cancer	0.00062	0.00168	CcSEcCtD
Sodium lauryl sulfate—Oedema—Epirubicin—thyroid cancer	0.00062	0.00168	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Doxorubicin—thyroid cancer	0.000617	0.00168	CcSEcCtD
Sodium lauryl sulfate—Infection—Epirubicin—thyroid cancer	0.000615	0.00167	CcSEcCtD
Sodium lauryl sulfate—Shock—Epirubicin—thyroid cancer	0.00061	0.00165	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Doxorubicin—thyroid cancer	0.000609	0.00165	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Epirubicin—thyroid cancer	0.000605	0.00164	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Epirubicin—thyroid cancer	0.000599	0.00163	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Doxorubicin—thyroid cancer	0.000598	0.00162	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Doxorubicin—thyroid cancer	0.000596	0.00162	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Epirubicin—thyroid cancer	0.000591	0.0016	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Epirubicin—thyroid cancer	0.000579	0.00157	CcSEcCtD
Sodium lauryl sulfate—Oedema—Doxorubicin—thyroid cancer	0.000573	0.00156	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000573	0.00156	CcSEcCtD
Sodium lauryl sulfate—Infection—Doxorubicin—thyroid cancer	0.000569	0.00155	CcSEcCtD
Sodium lauryl sulfate—Shock—Doxorubicin—thyroid cancer	0.000564	0.00153	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Doxorubicin—thyroid cancer	0.000559	0.00152	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Epirubicin—thyroid cancer	0.000556	0.00151	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000554	0.0015	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Epirubicin—thyroid cancer	0.000552	0.0015	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Doxorubicin—thyroid cancer	0.000546	0.00148	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Epirubicin—thyroid cancer	0.000539	0.00146	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Doxorubicin—thyroid cancer	0.000536	0.00145	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Epirubicin—thyroid cancer	0.000534	0.00145	CcSEcCtD
Sodium lauryl sulfate—Constipation—Epirubicin—thyroid cancer	0.00053	0.00144	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Doxorubicin—thyroid cancer	0.000515	0.0014	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Doxorubicin—thyroid cancer	0.000511	0.00139	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000507	0.00138	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Doxorubicin—thyroid cancer	0.000498	0.00135	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Doxorubicin—thyroid cancer	0.000494	0.00134	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Epirubicin—thyroid cancer	0.000492	0.00134	CcSEcCtD
Sodium lauryl sulfate—Constipation—Doxorubicin—thyroid cancer	0.00049	0.00133	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Epirubicin—thyroid cancer	0.00049	0.00133	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Epirubicin—thyroid cancer	0.00049	0.00133	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000469	0.00127	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Epirubicin—thyroid cancer	0.000456	0.00124	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Doxorubicin—thyroid cancer	0.000455	0.00124	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Doxorubicin—thyroid cancer	0.000453	0.00123	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Doxorubicin—thyroid cancer	0.000453	0.00123	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Epirubicin—thyroid cancer	0.000445	0.00121	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Epirubicin—thyroid cancer	0.000438	0.00119	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Epirubicin—thyroid cancer	0.000424	0.00115	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Doxorubicin—thyroid cancer	0.000422	0.00115	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Doxorubicin—thyroid cancer	0.000411	0.00112	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Epirubicin—thyroid cancer	0.00041	0.00111	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Doxorubicin—thyroid cancer	0.000406	0.0011	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Epirubicin—thyroid cancer	0.000394	0.00107	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Doxorubicin—thyroid cancer	0.000392	0.00106	CcSEcCtD
Sodium lauryl sulfate—Rash—Epirubicin—thyroid cancer	0.000391	0.00106	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Epirubicin—thyroid cancer	0.00039	0.00106	CcSEcCtD
Sodium lauryl sulfate—Headache—Epirubicin—thyroid cancer	0.000388	0.00105	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Doxorubicin—thyroid cancer	0.000379	0.00103	CcSEcCtD
Sodium lauryl sulfate—Nausea—Epirubicin—thyroid cancer	0.000368	0.000999	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Doxorubicin—thyroid cancer	0.000364	0.000989	CcSEcCtD
Sodium lauryl sulfate—Rash—Doxorubicin—thyroid cancer	0.000361	0.000981	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Doxorubicin—thyroid cancer	0.000361	0.00098	CcSEcCtD
Sodium lauryl sulfate—Headache—Doxorubicin—thyroid cancer	0.000359	0.000975	CcSEcCtD
Sodium lauryl sulfate—Nausea—Doxorubicin—thyroid cancer	0.00034	0.000924	CcSEcCtD
